N-hexane is a clear colorless liquids with a petroleum-like odor. Flash points -9°F. Less dense than water and insoluble in water. Vapors heavier than air. Used as a solvent, paint thinner, and chemical reaction medium.
颜色/状态:
Liquid
气味:
Gasoline-like odor
蒸汽密度:
2.97 (NTP, 1992) (Relative to Air)
蒸汽压力:
153 mm Hg at 25 °C
大气OH速率常数:
5.61e-12 cm3/molecule*sec
自燃温度:
437 °F (225 °C)
分解:
When heated to decomposition it emits acrid smoke and fumes.
Different levels of physical activity, namely, rest, 25 W, and 50 W (for 12 hr followed by 12 hr at rest) were simulated to assess the impact of work load on the recommended biological exposure indices: ...free (nonhydrolyzed) 2,5-hexanedione (a metabolite of n-hexane) at the end of the shift at the end of the workweek. ... Urinary 2,5-hexanedione predicted for 50 ppm was 1.07 mg/L at 50 W and 0.92 mg/L at rest (+16%). ...
IDENTIFICATION: n-Hexane is a straight chain saturated hydrocarbon obtained from certain petroleum fractions after various thermal or catalytic cracking steps. Commercial hexane may contain from 20%-85& n-Hexane and various amounts of hexane isomer, 2-methylpentane, 3-methylpentane, 2-3-dimethylbutene, cyclopentane, cyclohexane and small quantities of pentane and heptane isomers, acetone, methyl ethyl ketone, dichloromethane and trichloroethylene. Trace amounts of benzene may be present. N-Hexane is a colorless liquid and solubility in water is low. It is miscible with alcohol, chloroform and ether. Main uses are: rubber and adhesive solvent in shoe factories; extraction of soybean oil, callous seed oil and flaxseed oil. It is used in the pharmaceutical and cosmetic industries and is a cleaning agent for textiles, furniture and leather products. N-Hexane is also used for: determination of the refractive index of minerals, filling for thermometers and denaturant. HUMAN EXPOSURE: The target organs are: central nervous system and peripheral nervous system, respiratory system, heart, skin and eyes. Chemical pneumonia can occur after ingestion and and aspiration to the lungs. CNS depression, convulsions, coma and death may follow acute exposures to large concentrations. Inhalation of n-hexane usually causes eye, nose, throat and respiratory irritation, which are rapidly reversible when exposure is discontinued. Symptoms are more severe is ingestion or inhalation are associated with exposure to other hydrocarbons which may potentiate the effects. Exogenous catecholamines may precipitate a fatal ventricular arrhythmia in the sensitized myocardium. Acute exposure to considerable concentrations of n-hexane may cause cough, wheezing, bloody frothy sputum, headache, dizziness, tachycardia and fever. Gastrointestinal symptoms may result. Respiratory system: slow and shallow respiration; aspiration of n-hexane may cause pulmonary edema and chemical pneumonia. Cardiovascular system: tachycardia and ventricular dysrhythmia. Central nervous system: vertigo, giddiness, CNS depression syndrome. In heavy exposures unconsciousness may result. Peripheral nervous system: chronic exposure may produce important peripheral neuropathy (motor sensory) and CNS abnormalities. Gastrointestinal tract: nausea, vomiting and anorexia. Adults may be exposed in the workplace or in case of suicide attempts. Glue sniffing or n-hexane sniffing puts individuals at risk. There is a potential for accidental ingestion may occur in children. Laboratory workers which use the solvent for extraction procedures, chemists and pharmacists may be exposed. In the factory, glues and adhesives industry employees and those in printing and painting occupations. N-Hexane is absorbed following inhalation, ingestion or by topical application to the skin. In human volunteers about 28% of inhaled n-Hexane was taken up by the lungs. Alveolar retention is about 25% of the inhaled dose of n-hexane and the final absorption is 15%-17% in relation to the total respiratory uptake. Alveolar uptake was greater in obese individuals. Although the alveolar uptake rate decreased during physical exercise, the total uptake of n-hexane increased slightly as a result of the higher lung ventilation rate. Concentrations of n-hexane correlated with blood concentrations in industrial workers exposed to commercial hexane. It is poorly absorbed by the gastrointestinal system. Dermal absorption is very slow. Peak blood levels occur in less than 1 hour following inhalation or percutaneous exposure. N-Hexane has great affinity for high lipid content tissues and is rapidly metabolized to hydroxylated compounds before being converted to 2,5-hexanedione. The respiratory elimination of n-hexane in recently exposed workers was biphasic. The median half-lives of the fast and slow phases were 11minutes and 99 minutes. Workers exposed to n-hexane for about 7 hours/day without protective devices had the following metabolites in the urine: 2-hexanol, 2-methyl-2-pentanol, 3-methyl-2-pentanol, cyclohexanol, cyclohexane and trichloroethanol. In humans exposed to concentrations of up to 200 ppm, steady state blood levels were dose dependent; accumulation occurred in humans exposed to as little as 1 ppm. ANIMAL STUDIES: At the first step of oxidative metabolism by cytochrome p-450, the carbons 1,2,3 of n-hexane molecule are hydroxylated and form hexanols in different proportions in all species of animals. N-Hexane is metabolized by mixed function oxidase system in the liver forming alcohols which are conjugated to glucuronic acid or converted to carbon monoxide. 1-Hexanol and 3-hexonal are less toxic metabolites. The former is oxidized to hexanoic acid which undergoes the usual lipid metabolism. 2,5-Hexanedione was detected in urine. In rats exposed to n-hexane, important alterations in the quantity and composition of pulmonary surfactant in rats after short term exposure. The lungs of rats exposed to hexane at different concentrations showed a direct toxic effect on pneumocytes; fatty degeneration, change of alveolar bodies in type 2 pneumocytes and increased detachment of cells. Severe atrophy involving the seminiferous tubules with loss of the nerve growth factor in immunoreactive germ cell line of rats after 61 days of exposure was noted. Permanent testicular damage was found in some animals which had a total loss of the germ cell line lasting up to 14 months after the post exposure period. Simultaneous administration of n-hexane with toluene or xylene did not cause germ cell line alterations or testicular atrophy. In vitro toxicity of n-hexane and 2,5-hexanedione has been evaluated in the isolated perfused rabbit heart. The force of cardiac contraction was significantly reduced following 1 hour of perfusion with n-hexane or 2,5-hexanedione. Spinal neuron cell cultures exposed to n-hexane and butanone developed the neural swelling faster than when exposed to n-hexane. Animal tests have been negative for teratogenic effects. In pregnant rats showed n-hexane blood concentrations in the fetus equal to that found in maternal blood. Isopropanol enhances the induction of n-hexane metabolizing enzymes and increases the 2-hexanol concentrations in the liver and kidney. Methyl isobutyl ketone mixed with n-hexane significantly increased aniline hydroxylase and cytochrome P450 activity in the liver of exposed hens.
Hexane's toxicity is caused by it neurotoxic metabolite, 2,5-hexanedione. It damages the central and peripheral nervous system by causing axonal swelling and degeneration. 2,5-Hexanedione also reacts with lysine side-chain amino groups in axonal cytoskeletal proteins to form pyrroles. This results in neurofilament cross-linking and loss of function. (L175)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
致癌物分类
己烷存在于汽油中,对人类可能具有致癌性(2B组)。
Hexane is found in gasoline, which is possibly carcinogenic to humans (Group 2B). (L135)
Hexane mainly affects the nervous system. It causes degeneration of the peripheral nervous system (and eventually the central nervous system), starting with damage to the nerve axons. Exposure to hexane may also damage the lungs and reproductive system. (L977, L978)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
暴露途径
该物质可以通过吸入其蒸汽和摄入进入人体。
The substance can be absorbed into the body by inhalation of its vapour and by ingestion.
来源:ILO-WHO International Chemical Safety Cards (ICSCs)
吸收、分配和排泄
己烷通过肺部吸收,通过完整皮肤吸收相对较差。
Hexane is absorbed through the lungs and relatively poorly absorbed through the intact skin.
Accumulation in the tissues depends on lipid content in these tissues. n-/Hexane/ is oxidized in the liver. Excretion occurs via the lungs and kidneys. ... Excretion of /hexane/ is related to dose.
The pharmacokinetics of inhaled n-hexane in rat and man were compared. In the rat metabolism was saturable. Up to 300 ppm, the metabolic rate was directly proportional to the concentration in the atmosphere, reaching 47 umol/(hr X kg). Only 17% of n-hexane was exhaled unchanged. Above 300 ppm, the amount of n-hexane in the body rose with increasing atmospheric concentrations from 1.6 up to a limiting value of 9.6, which corresponded to the thermodynamic distribution coefficient of n-hexane between the organism and the atmosphere. Up to 3000 ppm, the rate of metabolism increased to 245 umol/(hr X kg); only a slow further increase was found up to 7000 ppm (285 umol/(hr X kg). In man the steady-state concentrations of n-hexane were about 1 ppm. The metabolic clearance was 132 1/hr, and n-hexane accumulated to a factor of 2.3 in the organism. The thermodynamic distribution coefficient was calculated to be 12. Twenty per cent of n-hexane in the body was exhaled unchanged. At low concentrations the rate of metabolism of n-hexane is limited in both species by transport to the enzyme system. Under these conditions the rate of metabolism of n-hexane should not be influenced by xenobiotics which induce the n-hexane metabolizing enzyme system.
... Male Fischer 344 rats were exposed to 500, 1000, 3000 or 10,000 ppm (14)C-n-hexane for 6 hr and the elimination of radioactivity followed for 72 hr after exposure. The disposition of radioactivity was dose-dependent, with 12, 24, 38 and 62% of the acquired body burden excreted as n-hexane by the lung with increasing exposure concentration. In contrast, 38, 31, 27 and 18% of the body burden of radioactivity was recovered as expired (14)CO2 and 35, 40, 31 and 18% was recovered in the urine with increasing n-hexane concentration. Radioactivity remaining in the tissues and carcass 72 hr after exposure represented 6.1, 8.8, 7.4 and 5.4% of the body burden for the respective exposures. The dose-dependent elimination of radioactivity was apparently due in part to an inhibition of n-hexane metabolism, reflected by a decrease in total 14CO2 and urinary 14C excretion after 10,000 ppm exposure compared to the 3000 ppm exposure.
Insecticidal and acaricidal diarylpyrrolecarbonitrile and
申请人:American Cyanamid Company
公开号:US05180734A1
公开(公告)日:1993-01-19
This invention relates to new diarylpyrrolecarbonitrile and new diarylnitropyrrole compounds. It also relates to the use of said compounds as insecticidal and acaricidal agents and to a method of protecting plants, particularly crop plants, from attack by insects and acarina by application of a new diarylpyrrolecarbonitrile or diarylnitropyrrole to said plants or to the locus in which they are growing.
Silica–Dendrimer Core–Shell Microspheres with Encapsulated Ultrasmall Palladium Nanoparticles: Efficient and Easily Recyclable Heterogeneous Nanocatalysts
作者:Ankush V. Biradar、Archana A. Biradar、Tewodros Asefa
DOI:10.1021/la203066d
日期:2011.12.6
We report the synthesis, characterization, and catalytic properties of novel monodisperse SiO2@Pd-PAMAM core–shell microspheres containing SiO2 microsphere cores and PAMAM dendrimer-encapsulated Pd nanoparticle (Pd-PAMAM) shells. First, SiO2 microspheres, which were prepared by the Stöber method, were functionalized with vinyl groups by grafting their surfaces with vinyltriethoxysilane (VTS). The vinyl
Ambient Hydrogenation and Deuteration of Alkenes Using a Nanostructured Ni‐Core–Shell Catalyst
作者:Jie Gao、Rui Ma、Lu Feng、Yuefeng Liu、Ralf Jackstell、Rajenahally V. Jagadeesh、Matthias Beller
DOI:10.1002/anie.202105492
日期:2021.8.16
selective hydrogenation and deuteration of a variety of alkenes is presented. Key to success for these reactions is the use of a specific nickel-graphitic shell-based core–shell-structured catalyst, which is conveniently prepared by impregnation and subsequent calcination of nickel nitrate on carbon at 450 °C under argon. Applying this nanostructured catalyst, both terminal and internal alkenes, which
提出了各种烯烃的选择性氢化和氘化的通用方案。这些反应成功的关键是使用特定的镍-石墨壳基核壳结构催化剂,该催化剂可以通过浸渍碳上的硝酸镍并随后在氩气下于 450 °C 下煅烧来方便地制备。应用这种纳米结构催化剂,具有工业和商业重要性的末端烯烃和内部烯烃在环境条件下(室温,使用1巴氢气或1巴氘)进行选择性氢化和氘化,从而获得相应的烷烃和氘。标记烷烃的收率良好至极好。通过克级反应以及高效的催化剂回收实验证明了这种镍基加氢方案的合成效用和实用性。
Hydrogenation of arenes, nitroarenes, and alkenes catalyzed by rhodium nanoparticles supported on natural nanozeolite clinoptilolite
作者:Seyed Meysam Baghbanian、Maryam Farhang、Seyed Mohammad Vahdat、Mahmood Tajbakhsh
DOI:10.1016/j.molcata.2015.06.029
日期:2015.10
Nanozeolite clinoptilolite supported rhodiumnanoparticles (Rh/NZ-CP) has been prepared and characterized by a variety of techniques, including XRD, BET, TEM, EDX, ICP-OES and XPS analysis. This nanomaterial contains 2 wt% Rh in the range of 5–20 nm metallic nanoparticles distributed on nanozeolite. The catalytic performance of Rh/NZ-CP was evaluated by the hydrogenation of arenes, nitroarenes, and alkenes under
pharmaceutical industry. Here, we report on a nanostructured nickel catalyst that enables the selective hydrogenation of purely aliphatic and functionalized olefins under mild conditions. The earth-abundant metal catalyst allows the selective hydrogenation of sterically protected olefins and further tolerates functional groups such as carbonyls, esters, ethers and nitriles. The characterization of our
官能化烯烃的选择性加氢在化学和制药工业中具有重要意义。在这里,我们报告了一种纳米结构的镍催化剂,该催化剂能够在温和条件下对纯脂肪族和官能化烯烃进行选择性加氢。地球上丰富的金属催化剂允许空间保护的烯烃的选择性氢化,并进一步耐受羰基、酯、醚和腈等官能团。我们催化剂的表征揭示了表面氧化金属镍纳米颗粒的形成,该纳米颗粒由活性炭载体上的 N 掺杂碳层稳定。